Privi Speciality Chemicals delivered a standout performance in FY26, with revenue climbing 21.7% year-on-year to reach Rs. 2,582.92 crore. The company's profitability saw an even more dramatic rise; EBITDA jumped 40.3% to Rs. 665.45 crore, while PAT surged by 75.2%, settling at Rs. 327.54 crore.

The fourth quarter of FY26 showed similar strength, with revenue growing 15.5% to Rs. 725.70 crore and PAT increasing 40.9% to Rs. 93.70 crore. These results were driven by strong volume growth, an improved product mix, and efficient operations across its facilities.

Mahesh Babani, Chairman & Managing Director, highlighted the company's transformation into a more resilient and diversified organisation. "FY26 reflects strong execution across our business, with total income of Rs. 2,583 crore, up 22% year-on-year, driven by robust volume growth, improving product mix, and consistent operational performance," he stated.

During the year, the company undertook debottlenecking initiatives to support future growth and enhance capacity utilisation.

Operating cash flow for the year stood at Rs. 550 crore, and after investing Rs. 320 crore on CAPEX, total debt reduced by Rs. 113 crore.

The management has set a medium-term "5k:1k" vision, targeting Rs. 5,000 crore revenue and Rs. 1,000 crore EBITDA by FY29-30.